Status:
RECRUITING
Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery
Lead Sponsor:
Branch Office of "Hadassah Medical Ltd"
Collaborating Sponsors:
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Conditions:
Breast Cancer Stage I
Breast Cancer Stage II
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
There is currently no consensus on the "gold standard" for Implant-based Breast reconstruction. In the United States, more than half of all breast reconstructions are performed using acellular dermal ...
Eligibility Criteria
Inclusion
- White women;
- Breast cancer stage 0-II;
- Indications for breast reconstruction;
- Consent to participate in the study and photographic documentation.
Exclusion
- Non-white women;
- Breast cancer stage III-IV;
- Tubular breast;
- Mental and cognitive health disorders;
- Failure to comply with recommendations in the postoperative period (premature physical activity, not wearing compression underwear, missing scheduled visits, refusal of photo documentation);
- Patient refusal to participate in the study at any stage.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06931548
Start Date
March 1 2022
End Date
February 1 2026
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Branch of Hadassah Medical LTD
Moscow, Skolkovo Innovation Center, Russia, 121205